Drug name - Viltepso
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US10870676 | NIPPON SHINYAKU | Antisense nucleic acids |
Aug, 2031
(8 years from now) | |
| US9079934 | NIPPON SHINYAKU | Antisense nucleic acids |
Aug, 2031
(8 years from now) | |
| CN103154245B | NIPPON SHINYAKU | Antisense Nucleic Acid |
Aug, 2031
(8 years from now) | |
| CN103154245A | NIPPON SHINYAKU | Antisense Nucleic Acid |
Aug, 2031
(8 years from now) | |
| IN323500B | NIPPON SHINYAKU | Antisense Nucleic Acid |
Aug, 2031
(8 years from now) | |
| IN201302817P1 | NIPPON SHINYAKU | Antisense Nucleic Acid |
Aug, 2031
(8 years from now) | |
| EP3018211B1 | NIPPON SHINYAKU | Antisense Nucleic Acids |
Feb, 2022
(7 months ago) | |
| EP3018211A1 | NIPPON SHINYAKU | Antisense Nucleic Acids |
Feb, 2022
(7 months ago) | |
| EP2612917A4 | NIPPON SHINYAKU | Antisense Nucleic Acid |
Aug, 2031
(8 years from now) | |
| EP2612917A1 | NIPPON SHINYAKU | Antisense Nucleic Acid |
Aug, 2031
(8 years from now) | |
| EP2612917B1 | NIPPON SHINYAKU | Antisense Nucleic Acid |
Aug, 2031
(8 years from now) | |
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 250MG/5ML (50MG/ML) | SOLUTION;INTRAVENOUS | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.